- Home
- GVH vs OVID Comparison
GVH vs OVID Comparison
Compare GVH & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GVH
- OVID
- Stock Information
- Founded
- GVH 2016
- OVID 2014
- Country
- GVH Australia
- OVID United States
- Employees
- GVH N/A
- OVID N/A
- Industry
- GVH
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- GVH
- OVID Health Care
- Exchange
- GVH Nasdaq
- OVID Nasdaq
- Market Cap
- GVH 21.3M
- OVID 20.6M
- IPO Year
- GVH 2023
- OVID 2017
- Fundamental
- Price
- GVH $0.18
- OVID $0.34
- Analyst Decision
- GVH
- OVID Strong Buy
- Analyst Count
- GVH 0
- OVID 4
- Target Price
- GVH N/A
- OVID $3.13
- AVG Volume (30 Days)
- GVH 3.2M
- OVID 1.2M
- Earning Date
- GVH 02-12-2025
- OVID 08-12-2025
- Dividend Yield
- GVH N/A
- OVID N/A
- EPS Growth
- GVH 12.04
- OVID N/A
- EPS
- GVH 0.09
- OVID N/A
- Revenue
- GVH $16,540,178.00
- OVID $548,000.00
- Revenue This Year
- GVH N/A
- OVID N/A
- Revenue Next Year
- GVH N/A
- OVID $5.32
- P/E Ratio
- GVH $7.56
- OVID N/A
- Revenue Growth
- GVH N/A
- OVID 15.61
- 52 Week Low
- GVH $0.16
- OVID $0.24
- 52 Week High
- GVH $1.82
- OVID $1.47
- Technical
- Relative Strength Index (RSI)
- GVH 22.26
- OVID 61.02
- Support Level
- GVH $1.33
- OVID $0.29
- Resistance Level
- GVH $1.54
- OVID $0.32
- Average True Range (ATR)
- GVH 0.14
- OVID 0.03
- MACD
- GVH -0.14
- OVID 0.00
- Stochastic Oscillator
- GVH 0.99
- OVID 91.03
About GVH Globavend Holdings Limited
Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.